Table 1.
Patients’ characteristics.
| Variable | Categorization | Analyzable n (%) |
|---|---|---|
| Age | <60 years | 14 (20.6) |
| >60 years | 54 (79.4) | |
| Gender | Female | 42 (61.8) |
| Male | 36 (52.9) | |
| Melanoma site | Primary melanoma | 6 (8.8) |
| Lymph node | 41 (60.3) | |
| Recurrence | 19 (27.9) | |
| Others | 2 (2.9) | |
| Treatment | Surgery | 23 (35.3) |
| Radiotherapy | 4 (5.9) | |
| Chemotherapy/immunotherapy | 30 (44.1) | |
| Radiotherapy + chemotherapy | 10 (14.7) | |
| Surgery + radiotherapy | 1 (1.5) | |
| BRAF status | V600E | 27 (39.7) |
| V600K | 5 (7.4) | |
| Wild-type | 36 (52.9) | |
| Mitotic index | ≤5 mitoses/1 mm2 | 22 (32.3) |
| >5 mitoses/1 mm2 | 46 (67.7) |